Stock CL CRESCO LABS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Cresco Labs Inc.

Equities

CL

CA22587M1068

Market Closed - Canadian Securities Exchange
Other stock markets
 20:59:59 03/05/2024 BST 		5-day change 1st Jan Change
2.96 CAD 0.00% Intraday chart for Cresco Labs Inc. +4.96% +65.36%
04-15 Jushi Holdings Inc. Brief: Appointed Todd West as Chief Operating Officer, Effective April 12, 2024; Most Recent Role Was As Executive Vice President of Operations at Cresco Labs Inc MT
03-13 Cresco Labs Swings to Profit in Q4, Revenue Drops; Up 10.4% MT

Evolution of the average Target Price on Cresco Labs Inc.

Price target over the last 5 years

History of analyst recommendation changes

1ce11e9.Zj2u70IUA95WJGeqL9fuxyY4fTih5IXInU7TRfcwvW0.AASajgl1Zb0aQhfiebqxoURKDU_nt9Se23qkP4Bnjjo0dJmXElVJtQZgMg~689a852caa9d3ea1b44cc37413216d5f

Analyst Recommendations on Cresco Labs Inc.

TSX futures inch lower as oil prices fall; Fed minutes in focus RE
Wedbush Initiating Coverage of U.S. Cannabis: "Setting Stage for Greener Pastures: MT
GMP Stifel Reviews Cresco Labs' Q2 MT
Piper Sandler Cuts Cresco Labs' Target to US$6, Maintains Overweight Rating MT
Piper Sandler Maintains Overweight Rating, US$9 TP on Cresco Labs MT
Piper Sandler Cuts Cresco Labs TP to US$9 But Maintains Overweight Rating After Columbia Care Buy MT
Piper Sandler Keeps Overweight, US$14 TP on Cresco Labs After Q4, Columbia Care Deal MT
Piper Sandler Slightly Trims 2021 Sales Estimate on Cresco Labs, Maintains Overweight Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
2.163 USD
Average target price
4.363 USD
Spread / Average Target
+101.67%
High Price Target
13.02 USD
Spread / Highest target
+501.98%
Low Price Target
2.404 USD
Spread / Lowest Target
+11.13%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Cresco Labs Inc.

Piper Sandler
Stifel GMP

Ratings for Cresco Labs Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. CL Stock
  4. Consensus Cresco Labs Inc.